1. Home
  2. LPX vs MMED Comparison

LPX vs MMED Comparison

Compare LPX & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Louisiana-Pacific Corporation

LPX

Louisiana-Pacific Corporation

HOLD

Current Price

$74.21

Market Cap

4.9B

ML Signal

HOLD

Logo MiniMed Group Inc. Common Stock

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$19.44

Market Cap

5.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LPX
MMED
Founded
1973
1983
Country
United States
United States
Employees
N/A
2800
Industry
Forest Products
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.5B
IPO Year
1994
2026

Fundamental Metrics

Financial Performance
Metric
LPX
MMED
Price
$74.21
$19.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
10
Target Price
$105.29
$22.56
AVG Volume (30 Days)
1.2M
1.2M
Earning Date
05-06-2026
06-03-2026
Dividend Yield
1.67%
N/A
EPS Growth
N/A
N/A
EPS
0.76
N/A
Revenue
$2,708,000,000.00
N/A
Revenue This Year
N/A
$15.99
Revenue Next Year
$11.23
$10.00
P/E Ratio
$103.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$66.12
$10.65
52 Week High
$102.86
$19.76

Technical Indicators

Market Signals
Indicator
LPX
MMED
Relative Strength Index (RSI) 49.07 69.59
Support Level $73.90 $10.68
Resistance Level $77.41 N/A
Average True Range (ATR) 3.26 0.80
MACD 0.36 0.10
Stochastic Oscillator 44.75 87.26

Price Performance

Historical Comparison
LPX
MMED

About LPX Louisiana-Pacific Corporation

Louisiana-Pacific Corp is an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The Siding business of the company serves different markets with a broad product portfolio of engineered wood siding, trim, soffit, and fascia. The Company operates through three operating segments: Siding, OSB, and LP South America (LPSA). The company generates majority of its revenue from siding segment.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

Share on Social Networks: